Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 11/20 | 0.39 |
| ▸ | DRD4 | P21917 | 5/20 | 0.37 |
| ▸ | DRD3 | P35462 | 3/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | IKZF2 | Q9UKS7 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | CCR5 | P51681 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24790866 | 0.92 | DRD2 (0.39) | DRD2ADRA1AHDAC1CCR5 | |
| SCHEMBL24790924 | 0.87 | KDM4E (0.38) | DRD4IKZF2CACNA1ICCR5 | |
| SCHEMBL24790326 | 0.84 | IKZF1 (0.43) | DRD2ADRA1AHDAC1IKZF2CCR5 | |
| SCHEMBL25618774 | 0.83 | IKZF2 (0.32) | IKZF2KCNH2 | |
| SCHEMBL25625115 | 0.83 | AKT1 (0.36) | DRD2HDAC1KCNH2CCR5 | |
| SCHEMBL25619901 | 0.83 | IKZF1 (0.35) | DRD2DRD4DRD3CCR5 | |
| SCHEMBL24789054 | 0.82 | DRD4 (0.32) | DRD2DRD4DRD3 | |
| SCHEMBL24790875 | 0.82 | PRKAA2 (0.35) | — | |
| SCHEMBL24790237 | 0.82 | HRH3 (0.37) | DRD2DRD4DRD3 | |
| SCHEMBL25993223 | 0.82 | THRB (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3672949-B1 | 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF | NOVARTIS AG (CH) | 2022-12-21 | — | — | EP | disclosed |